Latest News

Some Scholar Rock Holding Corporation ( NASDAQ:SRRK ) shareholders may be a little concerned to see that the CEO...

Why National Energy Services Reunited is on investors’ radar National Energy Services Reunited (NasdaqCM:NESR) has drawn fresh attention after recent trading, with the stock closing at $23.71 and posting a 0.7% decline over the past day but gains over the past week and month. See our latest analysis for National Energy Services Reunited. Those short term moves sit on top of a much stronger backdrop, with a 90 day share price return of 17.96%, a year to date share price return of 50.16% and a...

Ameresco (NYSE:AMRC) secured a major solar PV project with Cook County, Illinois, adding a substantial renewable asset for the county. The company was awarded eight additional solar projects with Cook County, expanding its public sector clean energy portfolio. Ameresco also signed a new performance savings contract with Miami-Dade County, Florida, focused on energy efficiency and infrastructure upgrades. These announcements highlight Ameresco's expanding role in municipal sustainability and...

Wondering if Ford Motor's share price still offers value, or if the recent run has already done the heavy lifting for you? Over the last year the stock has returned 35.8%, compared with a 7.4% gain over the past month and a 5.3% decline year to date. This can signal shifting expectations around both opportunity and risk. Recent headlines have focused on Ford Motor's position in the US auto market and its ongoing investments in future vehicle platforms. These developments help frame how...

Caris Life Sciences (NasdaqGS:CAI) is promoting its Right-In-Time clinical trial solution, focused on closing the geographic gap in cancer trial access for community oncology practices across the US. The RIT model integrates trial matching into Caris' molecular profiling workflow and is designed to rapidly open eligible trials at local sites when a patient is identified. The initiative targets logistical and systemic barriers that often keep biomarker driven cancer trials concentrated in...

As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 1.91% amid easing geopolitical tensions and steady corporate earnings, investors are increasingly looking to dividend stocks as a reliable income source. In this context, selecting dividend stocks that offer stable yields can be particularly appealing for those seeking consistent returns in an environment where economic forecasts remain cautious.

We wouldn't blame The Travelers Companies, Inc. ( NYSE:TRV ) shareholders if they were a little worried about the fact...

Wondering if Safran at €272.50 is still offering value after a strong multi year run, or if the easy gains are behind it? This article focuses squarely on what the current price could mean for you. The stock is currently around €272.50, after a 25.6% return over 1 year and a 101.1% return over 3 years. Recent returns of 11.8% over 7 days, 5.2% over 30 days and 11.3% year to date show a pullback that may reflect shifting views on risk and reward. Recent coverage of Safran has focused on its...

DaVita (DVA) is back in focus after recent results showed 9.9% year on year revenue growth, earnings ahead of analyst estimates, and higher reimbursement rates that coincided with upbeat 2026 adjusted EPS guidance. See our latest analysis for DaVita. Investors have reacted strongly to DaVita’s recent results, with a 39.6% 90 day share price return and a 76.7% three year total shareholder return suggesting momentum has been building around the earnings story and reimbursement backdrop. If...

Recent share performance snapshot Pandora (CPSE:PNDORA) has drawn fresh attention after a recent pullback, with the share price down about 4.6% over the past day but slightly higher over the past month. Over the past 3 months, the stock shows a small decline, while year to date performance and the past year’s total return are both negative. This may prompt investors to reassess expectations and risk tolerance. See our latest analysis for Pandora. With the share price at DKK500.4, Pandora’s...

If you are wondering whether American Airlines Group at around US$11.50 is a bargain or a value trap, the starting point is understanding what the current price actually reflects. The stock has had a mixed run, with a 5.5% decline over the last 7 days, a 6.4% gain over the last 30 days, a 25.7% decline year to date and a 23.4% return over the past year. Recent headlines have focused on American Airlines Group's ongoing efforts to manage costs, capacity and debt, as well as industry wide...

If you are wondering whether Magna International's current share price lines up with its underlying worth, this article walks through the key facts to help you frame that question clearly. The stock last closed at $83.91, with returns of 8.2% over 7 days, 13.7% over 30 days, 11.9% year to date, 89.2% over 1 year, 33.8% over 3 years and an 18.3% decline over 5 years. These figures can change how investors think about both potential and risk. Recent coverage around auto components and mobility...

Activist pressure puts Teladoc Health (TDOC) in focus Activist investor Pineal Capital Management is pressing Teladoc Health (TDOC) to launch at least US$200 million in share buybacks and explore separating its Integrated Care and BetterHelp businesses. The push coincides with Teladoc’s work on AI powered safety features alongside Microsoft, putting both capital allocation and product direction under closer scrutiny for investors watching the stock. See our latest analysis for Teladoc...

Wondering whether Protagonist Therapeutics at around US$105.55 still offers value, or if most of the opportunity is already reflected in the price. The stock has posted returns of 0.1% over the past week, 7.1% over 30 days, 21.1% year to date and 128.7% over the last year, which may have shifted how investors think about both its potential and its risks. Recent news coverage has focused on Protagonist Therapeutics as a higher profile biotech name, with attention centered on its pipeline...

Ralph Lauren stock in focus after recent share move Ralph Lauren (RL) has drawn fresh attention after a recent share pullback of about 3% on the day, despite gains over the past month and past 3 months that keep longer term returns positive. See our latest analysis for Ralph Lauren. That 3% one day share price pullback sits against an 11% 30 day share price return and a 79% 1 year total shareholder return, suggesting long term momentum remains strong even as short term sentiment cools. If...

Accenture and Google Cloud launched the Gemini Enterprise Acceleration Program to scale industry specific AI agents and digital transformation for global enterprises. The program brings early access to Google DeepMind's Gemini models into Accenture client work, combining advanced AI with engineering talent and domain expertise. Offerings include pre built AI agents for sovereign and industry uses and Generative Content OS for marketing teams, aimed at AI powered workflows and customer...

Polestar Automotive Holding UK (NasdaqGM:PSNY) released full year 2025 results showing revenue of US$3.06b and a net loss of US$2.36b, a combination that keeps the stock in sharp focus for investors. See our latest analysis for Polestar Automotive Holding UK. The recent full year 2025 results and Q1 2026 retail sales update have arrived against a mixed backdrop, with the latest share price at US$18.11, a 30 day share price return of 3.72% and a 90 day share price return of 5.60%, but a 1 year...

Mountain Pacific Bancorp (MPCB) opened 2026 with Q1 revenue of US$9.5 million and basic EPS of US$0.43, set against trailing twelve month revenue of US$38.3 million and EPS of US$1.78 that reflect the latest phase of its earnings profile. Over the past year, revenue has moved from US$29.6 million to US$38.3 million on a trailing basis, while net income excluding extra items has shifted from US$7.8 million to US$12.4 million. This gives a clearer sense of how the top and bottom lines are...

Ryman Healthcare Limited reported that total sales of occupation right agreements for retirement village units rose to 331 in the fourth quarter ended 31 March 2026, up from 302 a year earlier. This lift in quarterly unit sales points to firmer demand for Ryman’s retirement village offering, an important indicator for ongoing village occupancy and cash generation. We’ll now examine how this stronger fourth-quarter unit sales performance shapes Ryman Healthcare’s investment narrative and...

As global markets experience a lift from de-escalating Middle East tensions and positive economic data, small-cap stocks have shown notable resilience, with the Russell 2000 Index rising by 11.89% year-to-date. In this environment of cautious optimism, identifying small-cap companies with strong fundamentals and noteworthy insider activity can offer intriguing opportunities for investors seeking growth potential amidst broader market momentum.

Capital One Financial (COF) opened 2026 with Q1 revenue of US$11.2b and basic EPS of US$3.35, alongside net income from continuing operations of US$2.1b, setting a clear marker for how the year is starting on both the top and bottom line. Over the past few quarters, the company has seen quarterly revenue range from US$7.6b in Q1 2025 to US$12.6b in Q3 2025, with basic EPS moving between US$1.39 and US$4.83 over that period. This gives investors a sense of how earnings per share have tracked...

If you are wondering whether Keurig Dr Pepper at around US$26.54 is a bargain or a value trap, this breakdown will help you assess whether the current price matches what you are actually getting. The stock has seen a 2.1% gain over the last 7 days, while returns sit around 0.0% over 30 days, a 4.3% decline year to date, and a 22.1% decline over the past year. This naturally raises questions about how the market currently views its prospects and risks. Recent news coverage has largely focused...

Investors may be wondering whether Fox is offering fair value after its recent run, or if the current price already reflects the story the market is paying for today. The stock last closed at US$65.56, with returns of 3.0% over 7 days, 14.5% over 30 days, an 11.1% year to date decline, 36.0% over 1 year, 109.7% over 3 years and 84.9% over 5 years. Recent headlines around Fox have focused on its position in the wider media sector and how the business is responding to shifts in viewing habits...

Global markets have been buoyed by positive developments, including de-escalation in the Middle East and strong earnings reports, leading to record highs in major U.S. indexes. As investors navigate these optimistic conditions, penny stocks continue to attract attention for their potential to offer both affordability and growth. Despite the term's vintage feel, penny stocks remain a relevant investment area for those interested in smaller or newer companies that demonstrate financial strength...